Fred B. Craves - Sep 13, 2024 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
Director
Signature
/s/ Mardi Dier, as Attorney-in-Fact
Stock symbol
MDGL
Transactions as of
Sep 13, 2024
Transactions value $
$0
Form type
4
Date filed
9/17/2024, 08:36 PM
Previous filing
Jun 27, 2024
Next filing
Nov 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDGL Common Stock Gift $0 -15K -4% $0.00 360K Sep 13, 2024 Direct
holding MDGL Common Stock 11.2K Sep 13, 2024 See Footnote F1
holding MDGL Common Stock 1.26K Sep 13, 2024 See Footnote F2
holding MDGL Common Stock 18K Sep 13, 2024 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares held indirectly by Dr. Craves through a grantor retained annuity trust.
F2 These securities are held by Bay City Capital LLC ("BCC"). Dr. Craves disclaims beneficial ownership of these securities held by BCC, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC.
F3 Represents shares held indirectly by Dr. Craves through the Craves Family Foundation.